Tectonic Therapeutic (TECX) Gains from Investment Securities (2017 - 2018)
Tectonic Therapeutic (TECX) posted quarterly Gains from Investment Securities of $150000.0 for Q2 2018, up 1150.0% quarter-over-quarter from $12000.0 in Q1 2018.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Gains from Investment Securities (2017 - 2018) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Gains from Investment Securities for 2 consecutive years, with $150000.0 the latest figure, recorded in Q2 2018.
- In Q2 2018, Gains from Investment Securities changed N/A year-over-year to $150000.0; the TTM figure through Sep 2019 stood at $150000.0 (down 13.29% YoY), while the FY2018 annual figure was $162000.0, up 852.94% from the prior year.
- Gains from Investment Securities rose to $150000.0 in Q2 2018 per TECX's latest filing, from $12000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $150000.0 in Q2 2018 and bottomed at $6000.0 in Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 150,000.00 |
| Mar 31, 2018 | 12,000.00 |
| Dec 31, 2017 | 11,000.00 |
| Sep 30, 2017 | 6,000.00 |